Myrtle Pharmaceutical Private Limited
About Myrtle Pharmaceutical Private Limited
Data last updated:
Myrtle Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85320DL2018PTC339853. Its GSTIN is 09AAMCM1292K1ZZ (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vijai Kumar Asthana and Ranvijay Singh.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at House No.605 Block – C Phase – 2 Holambi Kalan, Delhi, India – 110082.
As per the financials filed for FY 2021, the company reported a revenue of ₹14.96 Lakh, a decline of 23% compared to the previous year. For the same year it recorded a net profit of ₹1,173 (net margin 0.1%) and EBITDA of ₹19,221 (EBITDA margin 1.3%).
As per MCA filings, the company has open charges of ₹9 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressHouse No.605 Block – C Phase – 2 Holambi Kalan, Delhi, India – 110082
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Myrtle Pharmaceutical Private Limited
The main business activity of Myrtle Pharmaceutical is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Myrtle Pharmaceutical Private Limited FY 2021 filings available
Myrtle Pharmaceutical Private Limited reported revenue of ₹14.96 Lakh (down 23% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Myrtle Pharmaceutical Private Limited
Revenue fell 23% in the latest year. EBITDA fell 43% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Myrtle Pharmaceutical Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹19,221 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,173 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Myrtle Pharmaceutical Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.3% | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Myrtle Pharmaceutical are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Myrtle Pharmaceutical Private Limited
Myrtle Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Retail Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MPR Promoters & Developers Private Limited | ₹14.97 Lakh (FY 2016) | •••• | •••• | 469.0% | •••• | New Delhi, Delhi, India |
| Tasg Ventures Private Limited | ₹14.97 Lakh (FY 2025) | •••• | •••• | -92.0% | •••• | Iringallur, Kerala, India |
| Newsun Mercantile Company Private Limited | ₹14.97 Lakh (FY 2016) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Pearl Apparel Fashions Limited | ₹14.96 Lakh (FY 2020) | •••• | •••• | -86.0% | •••• | New Delhi, Delhi, India |
| Gugu Goods Private Limited | ₹14.96 Lakh (FY 2024) | •••• | •••• | -11.0% | •••• | Mumbai, Maharashtra, India |
| Myrtle Pharmaceutical Private Limited this company | ₹14.96 Lakh (FY 2021) | •••• | •••• | -23.0% | •••• | Delhi, India |
| SKLS Fabricators Private Limited | ₹14.95 Lakh (FY 2017) | •••• | •••• | -75.0% | •••• | Chennai, Tamil Nadu, India |
| Pratishtha Sales Private Limited | ₹14.95 Lakh (FY 2025) | •••• | •••• | 16.0% | •••• | Udaipur, Rajasthan, India |
| Arthnik Solutions Private Limited | ₹14.95 Lakh (FY 2025) | •••• | •••• | -77.0% | •••• | New Delhi, Delhi, India |
| Chooseberry Trading Private Limited | ₹14.95 Lakh (FY 2023) | •••• | •••• | -5.0% | •••• | Tiruchirappalli, Tamil Nadu, India |
| Mother Daughter Private Limited | ₹14.94 Lakh (FY 2022) | •••• | •••• | •••• | Jammu, Jammu and Kashmir, India |
Peers are the five companies nearest above and the five nearest below Myrtle Pharmaceutical by revenue in the same principal business activity (Retail Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Myrtle Pharmaceutical Private Limited
Myrtle Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijai Kumar Asthana | Director | 30 Sep 2018 | 8 Years 0 Months | Current |
| Ranvijay Singh | Director | 30 Sep 2018 | 8 Years 0 Months | Current |
| Neeraj Shukla | Director | 30 Sep 2018 | 8 Years 0 Months | Current |
Ownership and Shareholding of Myrtle Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Myrtle Pharmaceutical Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jan 2021 | Bank of India | ₹9 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Myrtle Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Myrtle Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Myrtle Pharmaceutical Private Limited
Myrtle Pharmaceutical Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Neeraj Shukla was appointed as Director on 30 Sep 2018.
Credit Ratings, Litigation & Regulatory Alerts for Myrtle Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Myrtle Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Myrtle Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Myrtle Pharmaceutical Private Limited
Myrtle Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAMCM1292K1ZZ | Uttar Pradesh | Active | 20 Nov 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Myrtle Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Myrtle Pharmaceutical Private Limited
Myrtle Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 September 2018 (8+ years old) and is registered under CIN U85320DL2018PTC339853.
Myrtle Pharmaceutical reported revenue of ₹14.96 Lakh for FY 2021 (down 23% YoY).
Myrtle Pharmaceutical has 3 current directors:
- Vijai Kumar Asthana - Director
- Ranvijay Singh - Director
- Neeraj Shukla - Director
Myrtle Pharmaceutical reported a net profit of ₹1,173 (net margin 0.1%) and EBITDA of ₹19,221 (EBITDA margin 1.3%) for FY 2021, as per its filed financial statements.
The GSTIN of Myrtle Pharmaceutical is 09AAMCM1292K1ZZ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Myrtle Pharmaceutical is U85320DL2018PTC339853. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Myrtle Pharmaceutical was incorporated on 30 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Myrtle Pharmaceutical by revenue are MPR Promoters & Developers Private Limited, Tasg Ventures Private Limited, Newsun Mercantile Company Private Limited, Pearl Apparel Fashions Limited, Gugu Goods Private Limited and 5 more, all in the same principal business activity (Retail Trading).
Neeraj Shukla was appointed as Director on 30 Sep 2018. Ranvijay Singh was appointed as Director on 30 Sep 2018. Vijai Kumar Asthana was appointed as Director on 30 Sep 2018.
The registered office of Myrtle Pharmaceutical is at House No.605 Block – C Phase – 2 Holambi Kalan, Delhi, India – 110082.
Myrtle Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.